Companies /Healthcare

Artivion Inc

NYSE: AORT Medical Devices
$23.30
▼ $0.67 (−2.80%) today
Markets closed · 3:14am ET

AORT at a Glance

Valuation
Market cap
$1.2B
Profitability
Revenue (TTM)
$471.5M
Profit margin
-0.7%
EPS (TTM)
$-0.07
Price
52-week range
$19 – $48
Street target
$40.91
Earnings
Next report
Nov 5, 2026

Headquartered in Kennesaw, GA Fiscal year ends December NYSE: AORT artivion.com

About Artivion

Artivion, Inc. (NYSE: AORT) is a medical device company focused on developing solutions for cardiac and vascular surgeons treating patients with aortic diseases. The company operates four major product groups: aortic stent grafts (including the AMDS platform), On-X mechanical heart valves (positioned as the leading aortic valve for patients under 65), surgical sealants (BioGlue), and implantable cardiac and vascular human tissue preservation services. Artivion markets and sells products in more than 100 countries worldwide. The company is building what it intends to be the only complete portfolio of aortic arch solutions through its existing AMDS system, the pending acquisition of Endospan's NEXUS Aortic Arch System (which recently received FDA PMA approval), and the Arcevo LSA pipeline program. The company is also advancing the ARTIZEN clinical trial as part of its aortic-focused R&D pipeline. Updated

Latest Activity

House trade disclosureGilbert Ray Cisneros, Jr.
  • AMDAdvanced Micro Devices, Inc. (AMD)Partial sell$1K – $15KAug 18
  • AGIO150 Main Street Trust > Bank of America Agios Pharmaceuticals, Inc. - Common StoBuy$1K – $15KAug 20
  • APH150 Main Street Trust > Bank of America Amphenol Corporation Common Stock (APH)Buy$1K – $15KAug 18
  • APG150 Main Street Trust > Bank of America APi Group Corporation Common Stock (APG)Buy$1K – $15KAug 4
  • APP150 Main Street Trust > Bank of America Applovin Corporation - Class A Common StPartial sell$1K – $15KAug 18
  • AORT150 Main Street Trust > Bank of America Artivion, Inc. Common Stock (AORT)Buy$1K – $15KAug 20
  • ATRCAtriCure, Inc. - Common Stock (ATRC)Buy$1K – $15KAug 20
  • BSX150 Main Street Trust > Bank of America Boston Scientific Corporation Common StoBuy$1K – $15KAug 18
+ 42 more trades in this filing
Made public 37 days after the earliest trade

Fifty-eight transactions in one filing amount to a full portfolio rebuild: bigger-ticket buys in Microsoft, Eaton, Quanta Services and Globus Medical, funded partly by repeated Lamar Advertising sales and trims in AMD, Nvidia and Meta. The rotation leans toward power, infrastructure and medical devices while chip and ad-tech exposure comes down. Disclosed 37 days after the earliest trades.

Read more

AORT Coverage

Frequently Asked Questions

What does Artivion do?

Artivion, Inc. (NYSE: AORT) is a medical device company focused on developing solutions for cardiac and vascular surgeons treating patients with aortic diseases.

What is the AORT stock price target?

The Wall Street consensus 12-month price target for AORT is $40.91.